Spyre Therapeutics Inc

NEW
STU:3920 (USA)  
€ 85 -2.5 (-2.86%) Jul 31
At Loss
P/B:
15.05
Market Cap:
€ 7.41B ($ 8.54B)
Enterprise V:
€ 6.90B ($ 7.96B)
Volume:
20.00
Avg Vol (2M):
86.00
Trade In:

My Checklist

Inactive
Item Name
Rating
Action

Fair Value Votes

Date Voted
Fair Value
Price on Date Voted
% Change Since Voted
% Change Relative to SP500
10/Page
Total 0

My Votes

My Vote : €